Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0920646 (
renal ischemia
)
2,515
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Neutrophil activation to release granules containing proteases and other enzymes is a primary cause of tissue damage during ischemia/reperfusion injury. Because the contribution of specific granule enzymes to this injury remains poorly defined, the role of
cathepsin G
in
renal ischemia
/reperfusion injury was tested. Bilateral
renal ischemia
led to the expiration of 64% of wild-type mice within 4 days of reperfusion, whereas all
cathepsin G
-deficient mice survived. Serum creatinine increased to similar levels at 24 hours after reperfusion and then decreased to background in both groups of mice. Ischemic kidneys from both groups had similar levels of neutrophil infiltration and of CXCL1, CXCL2, and myeloperoxidase protein 9 hours after reperfusion, but at 24 hours, these acute inflammatory response components were decreased more than 50% in kidneys from
cathepsin G
-deficient versus wild-type mice. Ischemic kidneys from surviving wild-type mice had severe tubular necrosis and tubular cell apoptosis 24 hours after reperfusion with subsequent development of fibrosis 30 days later. In contrast, ischemic kidneys from
cathepsin G
-deficient mice had a 70% decrease in tubular cell apoptosis with little detectable collagen deposition. These data identify
cathepsin G
as a critical component sustaining neutrophil-mediated acute tissue pathology and subsequent fibrosis after
renal ischemia
/reperfusion injury.
...
PMID:Cathepsin g is required for sustained inflammation and tissue injury after reperfusion of ischemic kidneys. 1732 78